SRC and cancer: Indeed, treatment of both patient-derived cancer cell lines with rCCL2 significantly enhanced the phosphorylation of paxillin already after 15 minutes of treatment (Figure 3, F and G), as well as of its downstream mediators Src and Erk (Supplemental Figure 6, G–J).